Abatacept for the treatment of rheumatoid arthritis after the failure of conventional disease-modifying antirheumatic drugs
School of Health and Related Research (ScHARR)
Record ID 32011000829
English
Authors' recommendations:
Abatacept in combination with methotrexate is not recommended for the treatment of moderate-to-severe,
active rheumatoid arthritis in adults whose disease has responded inadequately to one or more
conventional non-biological DMARDs including methotrexate.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.nets.nihr.ac.uk/projects/hta/102401
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Antirheumatic Agents
- Immunoconjugates
- Tumor Necrosis Factor-alpha
- Arthritis, Rheumatoid
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
<p>2011 Queen's Printer and Controller of HMSO</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.